新型无创超声振动弹性成像技术评估勃起功能障碍与佩罗尼病
该试点研究将超声振动弹性成像(UVE)用于勃起功能障碍或佩罗尼病患者,在注射勃起药物前后以100、150、200 Hz测量阴茎海绵体黏弹性。结果显示注射后黏弹性显著增加,且基线值与达到勃起所需药物体积相关,提示UVE可能成为勃起功能障碍的诊断工具。
要点
- UVE可在100、150、200 Hz无创测量阴茎海绵体黏弹性。
- 注射勃起药物后黏弹性显著增加,验证UVE可测动态变化。
- 基线黏弹性与所需勃起药物体积相关,与年龄和IIEF-EF无关。
核心结论
- UVE是首个在人类中评估勃起功能的弹性成像技术,与勃起注射药物反应性显著相关,值得进一步研究和验证。
研究设计与样本
- 试点研究,纳入勃起功能障碍或佩罗尼病患者,在阴茎两侧以100、150、200 Hz于勃起注射前后各测三次。
主要发现
- 勃起注射后黏弹性显著增加。
- 基线黏弹性与达到勃起所需勃起药物体积相关:100 Hz时参数估计2.21,P<.001;150 Hz时参数估计0.53,P=.03;200 Hz时参数估计0.34,P=.07。
- 基线黏弹性与年龄及国际勃起功能指数-勃起功能域无显著相关。
关键数值与推荐
- 测量频率为100、150、200 Hz,于阴茎两侧各测三次。
- 基线黏弹性与所需勃起药物体积的关联:100 Hz参数估计2.21,P<.001;150 Hz参数估计0.53,P=.03;200 Hz参数估计0.34,P=.07。
临床怎么用
- UVE可作为评估勃起功能障碍的无创诊断手段,尤其反映对勃起注射药物的反应性。
- 临床应用中需在100、150、200 Hz下于阴茎两侧重复测量。
局限性
- 为试点研究,样本量未报告,结论需进一步研究和验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To translate a novel ultrasound vibro-elastography (UVE) technique for noninvasively measuring viscoelasticity of the penis. METHODS: A pilot study of UVE was performed in men with erectile dysfunction or Peyronie disease. Assessments were performed in triplicate on the lateral aspect of the penis (bilaterally) at 100, 150, and 200 Hz before and after erectogenic injection administration. Viscoelasticity of the corpora was also calculated and compared before and after injection and against measures of erectile function, including the International Index of Erectile Function-Erectile Function Domain, and the total erectogenic medication volume required for achieving a firm erection. RESULTS: Significant increases in viscoelasticity were found after erectogenic injection, validating the ability of UVE to measure dynamic changes with erections. Baseline measures also significantly correlated with the volume of erectogenic medication required to achieve an erection (100 Hz, parameter estimate [PE] 2.21, P <.001; 150 Hz, PE 0.53, P = .03; 200 Hz, PE 0.34, P = .07) but not with age and International Index of Erectile Function-Erectile Function Domain. As erectogenic medications likely represent the most accurate measure of erectile function, these findings suggest a potential role for UVE as a viable diagnostic modality for erectile dysfunction. CONCLUSION: This first report of the use of elastography with erectile function in humans demonstrates significant associations with responsiveness to erectogenic injection medications. These data have significant potential implications for broader clinical practice and merit further study and validation.
引用
- Zhang X, Zhou B, Miranda AF, et al. A Novel Noninvasive Ultrasound Vibro-elastography Technique for Assessing Patients With Erectile Dysfunction and Peyronie Disease. Urology. 2018. PMID: 29548864. doi:10.1016/j.urology.2018.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。